Literature DB >> 22940024

Translational findings from cardiovascular stem cell research.

Ramesh Mazhari1, Joshua M Hare.   

Abstract

The possibility of using stem cells to regenerate damaged myocardium has been actively investigated since the late 1990s. Consistent with the traditional view that the heart is a "postmitotic" organ that possesses minimal capacity for self-repair, much of the preclinical and clinical work has focused exclusively on introducing stem cells into the heart, with the hope of differentiation of these cells into functioning cardiomyocytes. This approach is ongoing and retains promise but to date has yielded inconsistent successes. More recently, it has become widely appreciated that the heart possesses endogenous repair mechanisms that, if adequately stimulated, might regenerate damaged cardiac tissue from in situ cardiac stem cells. Accordingly, much recent work has focused on engaging and enhancing endogenous cardiac repair mechanisms. This article reviews the literature on stem cell-based myocardial regeneration, placing emphasis on the mutually enriching interaction between basic and clinical research.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22940024      PMCID: PMC3563254          DOI: 10.1016/j.tcm.2012.05.017

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  51 in total

Review 1.  Cardiac cell therapy: lessons from clinical trials.

Authors:  Philippe Menasche
Journal:  J Mol Cell Cardiol       Date:  2010-06-30       Impact factor: 5.000

2.  Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Authors:  Gerd P Meyer; Kai C Wollert; Joachim Lotz; Jan Steffens; Peter Lippolt; Stephanie Fichtner; Hartmut Hecker; Arnd Schaefer; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Circulation       Date:  2006-03-06       Impact factor: 29.690

3.  Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

Authors:  Timothy J Nelson; Almudena Martinez-Fernandez; Satsuki Yamada; Carmen Perez-Terzic; Yasuhiro Ikeda; Andre Terzic
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

4.  Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.

Authors:  Konstantinos E Hatzistergos; Henry Quevedo; Behzad N Oskouei; Qinghua Hu; Gary S Feigenbaum; Irene S Margitich; Ramesh Mazhari; Andrew J Boyle; Juan P Zambrano; Jose E Rodriguez; Raul Dulce; Pradip M Pattany; David Valdes; Concepcion Revilla; Alan W Heldman; Ian McNiece; Joshua M Hare
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

5.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

6.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

7.  Regenerating functional myocardium: improved performance after skeletal myoblast transplantation.

Authors:  D A Taylor; B Z Atkins; P Hungspreugs; T R Jones; M C Reedy; K A Hutcheson; D D Glower; W E Kraus
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

8.  Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.

Authors:  Jay H Traverse; Timothy D Henry; Douglas E Vaughan; Douglas E Vaughn; Stephen G Ellis; Carl J Pepine; James T Willerson; David X M Zhao; Linda B Piller; Marc S Penn; Barry J Byrne; Emerson C Perin; Adrian P Gee; Antonis K Hatzopoulos; David H McKenna; John R Forder; Doris A Taylor; Christopher R Cogle; Rachel E Olson; Beth C Jorgenson; Shelly L Sayre; Rachel W Vojvodic; David J Gordon; Sonia I Skarlatos; Lemuel A Moye'; Robert D Simari
Journal:  Am Heart J       Date:  2009-07-23       Impact factor: 4.749

9.  Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential.

Authors:  Tom J Burdon; Arghya Paul; Nicolas Noiseux; Satya Prakash; Dominique Shum-Tim
Journal:  Bone Marrow Res       Date:  2010-12-06

10.  Cardiac cell therapy: overexpression of connexin43 in skeletal myoblasts and prevention of ventricular arrhythmias.

Authors:  Sarah Fernandes; Harold V M van Rijen; Virginie Forest; Stéphane Evain; Anne-Laure Leblond; Jean Mérot; Flavien Charpentier; Jacques M T de Bakker; Patricia Lemarchand
Journal:  J Cell Mol Med       Date:  2009-03-06       Impact factor: 5.310

View more
  11 in total

1.  Adult stem cells and cardiac regeneration.

Authors:  Kursad Turksen
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

2.  Mesenchymal Stem Cells Improve Heart Rate Variability and Baroreflex Sensitivity in Rats with Chronic Heart Failure.

Authors:  Sharon Del Bem Velloso de Morais; Luiz Eduardo Virgilio da Silva; Renata Maria Lataro; Carlos Alberto Aguiar Silva; Luciano Fonseca Lemos de Oliveira; Eduardo Elias Vieira de Carvalho; Marcus Vinicius Simões; Lindolfo da Silva Meirelles; Rubens Fazan; Helio Cesar Salgado
Journal:  Stem Cells Dev       Date:  2015-06-24       Impact factor: 3.272

3.  Effect of intravenous cell therapy in rats with old myocardial infarction.

Authors:  Xian-Liang Tang; Marcin Wysoczynski; Anna M Gumpert; Yan Li; Wen-Jian Wu; Hong Li; Heather Stowers; Roberto Bolli
Journal:  Mol Cell Biochem       Date:  2021-11-16       Impact factor: 3.396

Review 4.  Remodeling and dedifferentiation of adult cardiomyocytes during disease and regeneration.

Authors:  Marten Szibor; Jochen Pöling; Henning Warnecke; Thomas Kubin; Thomas Braun
Journal:  Cell Mol Life Sci       Date:  2013-12-10       Impact factor: 9.261

Review 5.  Cardiac stem cells: biology and clinical applications.

Authors:  Polina Goichberg; Jerway Chang; Ronglih Liao; Annarosa Leri
Journal:  Antioxid Redox Signal       Date:  2014-04-10       Impact factor: 8.401

Review 6.  The advancing field of cell-based therapy: insights and lessons from clinical trials.

Authors:  Kartik S Telukuntla; Viky Y Suncion; Ivonne H Schulman; Joshua M Hare
Journal:  J Am Heart Assoc       Date:  2013-10-10       Impact factor: 5.501

Review 7.  Rethinking cardiac metabolism: metabolic cycles to refuel and rebuild the failing heart.

Authors:  Heinrich Taegtmeyer; Genna Lubrano
Journal:  F1000Prime Rep       Date:  2014-10-01

Review 8.  Perspectives of pluripotent stem cells in livestock.

Authors:  Dharmendra Kumar; Thirumala R Talluri; Naresh L Selokar; Iqbal Hyder; Wilfried A Kues
Journal:  World J Stem Cells       Date:  2021-01-26       Impact factor: 5.326

Review 9.  Large animal models for stem cell therapy.

Authors:  John Harding; R Michael Roberts; Oleg Mirochnitchenko
Journal:  Stem Cell Res Ther       Date:  2013-03-28       Impact factor: 6.832

Review 10.  Strategies affording prevascularized cell-based constructs for myocardial tissue engineering.

Authors:  Claudio Muscari; Emanuele Giordano; Francesca Bonafè; Marco Govoni; Carlo Guarnieri
Journal:  Stem Cells Int       Date:  2014-01-05       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.